Basal Cell Carcinoma Infiltrating the Facial Bones—Is It Really a Thing of the Past? Personal Experience over 30 Years and a Review of the Literature

<b>Background/Objectives:</b> Basal cell carcinoma (BCC) is the most common form of skin cancer, typically exhibiting slow growth and limited metastatic potential. However, in rare, long-standing cases, particularly in high-risk facial regions, deep infiltration into structures such as bone may occur. This study aimed to evaluate whether BCC with bone involvement remains a relevant clinical issue, based on three decades of clinical experience, supplemented by a review of the existing literature. <b>Methods:</b> Medical records of patients treated for facial BCC between 1994 and 2025 at a dermatologic surgery department in Lower Silesia were retrospectively reviewed. Among more than 10,000 cases, eight instances of histologically confirmed bone invasion were identified. Clinical and surgical parameters were analyzed, including patient age, tumor size and location, prior treatment and reconstruction method. Relevant literature was incorporated to provide broader clinical context. <b>Results:</b> Patients with bone-invasive BCC were elderly (mean age: 75.3 years, SD: 10.94 years) and lesions were typically large (mean diameter 38.9 mm), most frequently located on the nose and forehead. Many cases lacked previous treatment. Smaller nasal tumors were managed with local flaps, while larger lesions on the forehead and temple required skin grafts. Findings from the literature confirm that bone invasion is rare and usually associated with long-standing tumors in anatomically high-risk areas. <b>Conclusions:</b> Although rare, BCC with bone infiltration remains a clinically relevant phenomenon, particularly in elderly patients with advanced or recurrent tumors. Early diagnosis, complete excision with histologically clear margins, and individualized surgical planning are essential to prevent deep tissue involvement. Imaging should be reserved for cases in which advanced local invasion is clinically suspected.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-12-29
DOI
https://doi.org/10.3390/jcm15010254
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Basal Cell Carcinoma Infiltrating the Facial Bones—Is It Really a Thing of the Past? Personal Experience over 30 Years and a Review of the Literature

J. Szepietowski, Urszula Kozińska, Klaudia Knecht-Gurwin, Andrzej Bieniek et al.
Journal of Clinical Medicine
Nonmelanoma Skin Cancer Studies
article

Basal Cell Carcinoma Infiltrating the Facial Bones—Is It Really a Thing of the Past? Personal Experience over 30 Years and a Review of the Literature

J. Szepietowski, Urszula Kozińska, Klaudia Knecht-Gurwin, Andrzej Bieniek, Filip Majda, Iwona Chlebicka
article en

Abstract

<b>Background/Objectives:</b> Basal cell carcinoma (BCC) is the most common form of skin cancer, typically exhibiting slow growth and limited metastatic potential. However, in rare, long-standing cases, particularly in high-risk facial regions, deep infiltration into structures such as bone may occur. This study aimed to evaluate whether BCC with bone involvement remains a relevant clinical issue, based on three decades of clinical experience, supplemented by a review of the existing literature. <b>Methods:</b> Medical records of patients treated for facial BCC between 1994 and 2025 at a dermatologic surgery department in Lower Silesia were retrospectively reviewed. Among more than 10,000 cases, eight instances of histologically confirmed bone invasion were identified. Clinical and surgical parameters were analyzed, including patient age, tumor size and location, prior treatment and reconstruction method. Relevant literature was incorporated to provide broader clinical context. <b>Results:</b> Patients with bone-invasive BCC were elderly (mean age: 75.3 years, SD: 10.94 years) and lesions were typically large (mean diameter 38.9 mm), most frequently located on the nose and forehead. Many cases lacked previous treatment. Smaller nasal tumors were managed with local flaps, while larger lesions on the forehead and temple required skin grafts. Findings from the literature confirm that bone invasion is rare and usually associated with long-standing tumors in anatomically high-risk areas. <b>Conclusions:</b> Although rare, BCC with bone infiltration remains a clinically relevant phenomenon, particularly in elderly patients with advanced or recurrent tumors. Early diagnosis, complete excision with histologically clear margins, and individualized surgical planning are essential to prevent deep tissue involvement. Imaging should be reserved for cases in which advanced local invasion is clinically suspected.

Journal of Clinical MedicineVol. 15(1)
Wrocław University of Science and Technology (PL), Military Hospital (PK), Wroclaw Medical University (PL), Wroclaw University of Health and Sport Sciences (PL), AGH University of Krakow (PL)
Good health and well-being
Openalex Percentile: Top 28%
Nonmelanoma Skin Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Basal Cell Carcinoma Infiltrating the Facial Bones—Is It Really a Thing of the Past? Personal Experience over 30 Years and a Review of the Literature — J. Szepietowski, Urszula Kozińska, et al. · Journal of Clinical Medicine (2025) | TGRS Research Map | TGRS